Tattoos and cutaneous squamous cell carcinoma: a population-based case-control study.

Eur J Epidemiol

Division of Occupational and Environmental Medicine, Department of Laboratory Medicine, Lund University, Lund, Sweden.

Published: April 2025


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

The prevalence of tattoos in western countries is about 20%. Tattoo ink may contain carcinogenic compounds. The aim of this study was to investigate if tattoo exposure is associated with an increased risk of cutaneous squamous cell carcinoma in individuals. In this population-based case-control study, 2857 cases aged 20 to 60 years, diagnosed between 2014 and 2017, were identified in the Swedish Cancer Registry. Statistics Sweden identified 3 random age- and sex-matched controls per case from the Swedish Total Population Register using incidence-density sampling. In 2019, participants answered a questionnaire regarding lifestyle factors, including tattoos and sun habits. We used logistic regression to investigate if tattoo exposure was associated with the relative risk of cutaneous squamous cell carcinoma. 61% of the cases and 53% of the controls replied to the questionnaire. Among the 1600 cases and the 4551 controls that participated, 15.1% and 17.6% had at least one tattoo before the index date. We found no increased risk of cutaneous squamous cell carcinoma in tattooed compared with non-tattooed individuals (incidence rate ratio, 0.95; 95% confidence interval, 0.78-1.15). Tattoo exposure was not associated with the risk of cutaneous squamous cell carcinoma in this first study of the association. However, more epidemiologic studies are needed before consensus regarding a lack of association can be reached.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12145309PMC
http://dx.doi.org/10.1007/s10654-025-01230-zDOI Listing

Publication Analysis

Top Keywords

cutaneous squamous
20
squamous cell
20
cell carcinoma
20
risk cutaneous
16
tattoo exposure
12
exposure associated
12
population-based case-control
8
case-control study
8
investigate tattoo
8
increased risk
8

Similar Publications

Background: Non-melanoma skin cancers (NMSC) are the most frequent cutaneous tumors globally. Basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) represent the most frequently encountered representatives of this group and may represent a diagnosis challenge in some circumstances of hard to differentiate tumors.

Aims: The aim of this study was to determine the factors that influence the diagnosis of NMSC and their impact.

View Article and Find Full Text PDF

[Rare cause of pure white cell aplasia (PWCA) in a 76-year-old male patient].

Inn Med (Heidelb)

September 2025

Klinik für Innere Medizin - Hämatologie/Onkologie und Palliativmedizin, Ev. Stift St. Martin, Koblenz, Deutschland.

Pure white cell aplasia (PWCA) is a rare hematological condition characterized by the complete absence of granulocytes and myeloid precursor cells in the bone marrow. In this case report, we describe a 76-year-old patient with chronic lymphocytic leukemia (CLL) and cutaneous squamous cell carcinoma of the right upper eyelid who developed PWCA after treatment with the immune checkpoint inhibitor (ICI) cemiplimab. The PWCA is a rare side effect of checkpoint inhibitors.

View Article and Find Full Text PDF

Background: Despite overexpression of EGFR in head/neck squamous cell carcinoma (HNSCC), cetuximab monotherapy has limited benefit. Lenvatinib is a multi-targeted receptor tyrosine kinase inhibitor with activity against FGFRs1-4, involved in resistance to EGFR inhibition. We evaluated lenvatinib in combination with cetuximab in recurrent/metastatic (R/M) HNSCC.

View Article and Find Full Text PDF